Research Library
Analytical Quality and Testing·Quality·6 min read

Why 99% Purity Does Not Tell the Whole Story

A high purity number may look definitive, but it does not by itself prove molecular identity, actual peptide content, sterility, or suitability for a particular experiment.

By
Jacob Doyon, Researcher, Cendrix
Reviewed by
Jacob Leisher, Researcher, Cendrix
Published
March 29, 2026
Last reviewed
June 26, 2026
Key answer

A purity number such as 99 percent typically describes the relative proportion of the principal species detected by a single analytical method, usually HPLC at a defined wavelength. It does not establish identity, sequence, peptide content, counterion mass, water content, residual solvents, endotoxin, or biological activity. A complete picture requires multiple orthogonal methods and a method-specific certificate.

Key takeaways
  • [01]Purity is method-dependent and reports relative, not absolute, composition.
  • [02]Identity and purity are separate questions that require separate tests.
  • [03]Peptide content can differ substantially from gross vial mass due to water, counterions, and excipients.
  • [04]A useful certificate of analysis describes methods, conditions, and limits, not only a single number.

A purity percentage is one of the most visible numbers in the research-material market. It is also one of the easiest numbers to misunderstand. A result such as 99% purity may be useful, but only when the test method, sample, chromatogram, integration rules, and underlying identity of the material are known. By itself, the percentage cannot answer every question a researcher needs to ask.

In peptide analysis, purity often refers to the relative area of chromatographic peaks detected under a specified high-performance liquid chromatography method. That result can indicate how much of the detected material appears in the principal peak compared with other detectable peaks. It does not automatically establish that the principal peak is the intended peptide. A different compound, an isomer, a truncated sequence, or a closely related analogue could produce a dominant peak unless identity is evaluated independently.

Purity also differs from assay or peptide content. A vial may contain peptide, water, counterions, salts, and other residual material. Even if the peptide-related fraction is highly pure, the amount of actual peptide in the vial can differ from the total dry mass. That distinction matters when researchers compare lots, prepare analytical standards, or interpret concentration-dependent experimental results.

Other quality attributes answer entirely separate questions. Mass spectrometry can support molecular identity. Water testing can help explain gross mass and stability risk. Counterion analysis can clarify the chemical form. Residual-solvent testing addresses process chemicals not necessarily visible in a standard peptide-purity chromatogram. Endotoxin, bioburden, and sterility testing concern microbiological quality and cannot be inferred from HPLC purity.

The impurity profile matters as well as the headline percentage. FDA has emphasized that peptide-related impurities may affect safety or effectiveness and that highly similar impurities can be analytically and biologically important. A single total-purity figure can hide whether the remaining fraction consists of one prominent impurity, many low-level species, oxidation products, deletion sequences, or other process-related material.

This article is provided for scientific and educational purposes. It does not describe or recommend human or veterinary use. Research findings may be limited by study design, model selection, material identity, sample size, or lack of independent replication.

What the evidence supports
  • +HPLC purity values are detector- and wavelength-dependent and can miss species that do not absorb at the chosen wavelength.
  • +Peptide content assays based on amino acid analysis or nitrogen content provide independent confirmation of actual peptide mass.
  • +Orthogonal techniques such as mass spectrometry can detect impurities that co-elute on a single chromatographic method.
What the evidence does not establish
  • -That a high purity number proves identity, content, or activity.
  • -That two materials with similar purity claims from different sources are equivalent.
Cendrix analysis

purity should be treated as one field in a larger analytical record. A credible lot package should make clear what was tested, which method was used, what the result means, and what it does not mean. Precision begins when a number is placed in its proper scientific context, not when it is enlarged on a product page.

Frequently asked questions

Why are two 99 percent pure materials sometimes different?
Because the 99 percent figure describes one analytical view. Differences in counterion, water content, residual solvents, related impurities, or peptide content can still distinguish two lots that share a purity number.
What should a certificate of analysis include?
At minimum, identity confirmation, the method used to assess purity, the actual value with conditions, lot identifier, manufacturing and retest dates, storage conditions, and any applicable specialized testing such as endotoxin or residual solvents.

Selected primary references

  1. [1]FDA: ANDAs for Certain Highly Purified Synthetic Peptide Drug Products
  2. [2]FDA: Q6A Specifications and Test Procedures
  3. [3]Regulatory Guidelines for the Analysis of Therapeutic Peptides and Proteins

Editorial note. Written by Jacob Doyon and scientifically reviewed by Jacob Leisher. See our editorial standards, citation policy, and corrections policy.